Carna Health develops an AI-enabled digital platform to improve screening, monitoring and care management for chronic diseases, with a particular focus on chronic kidney disease (CKD). The company combines scalable point-of-care testing, predictive analytics and a patient-facing mobile app to identify risk, guide personalized treatment pathways and connect patients with providers.

Carna partners with health systems and industry organisations to expand access to early detection and precision intervention. Its platform improves patient awareness and engagement, supports primary care teams through decision support and upskilling, and streamlines care pathways to reduce progression to dialysis while also addressing related environmental impacts (CO2 emissions and water use).

Carna’s solution includes predictive models for disease risk and progression, localized patient campaigns, and automated care pathway tools for providers. The company emphasises global scalability, equitable access, and collaboration with partners to broaden reach and implement sustainable chronic disease programs.

Leadership: Salvatore G. Viscomi, MD, CEO & Co-Founder.